Pitney Bowes Beats Estimates - Pitney Bowes reported fourth-quarter 2011 earnings per share from continuing operations of 97 cents, above the Zacks Consensus Estimate of 60 cents.
on February 10, 2012
Dr Pepper Ups Shareholder Returns - Dr Pepper Snapple Group Inc. has increased its quarterly dividend by 6.3% to 34 cents per share, bringing its annualized dividend rate to $1.36 per share.
on February 9, 2012
Positive Results on Forest/Gedeon Drug - Preliminary top-line results were presented from a phase III study of cariprazine that was conducted in patients with acute mania associated with bipolar I disorder.
on February 9, 2012
Bristol-Myers, SNY Win Plavix Damages - Apotex settled the dispute regarding Plavix with co- developers Bristol-Myers and Sanofi
on February 9, 2012
Update on VPHM's Industrial Facility - ViroPharma Inc. recently announced that the US Food and Drug Administration has issued a complete response letter for Cinryze's industrial scale manufacturing facility.
on February 9, 2012
Outperform on Abiomed - We retain our Outperform recommendation on Abiomed following its impressive third quarter results.
on February 9, 2012
Newfield Kept at Neutral Rec - We are maintaining our Neutral recommendation on Texas-based Newfield Exploration Company.
on February 9, 2012
Citi Entangled in Lawsuit Again - Citibank, the banking unit of Citi, has been sued by Lehman for wrongly confiscating nearly $2.5 billion, which was transferred by Lehman just before its bankruptcy filing in 2008.
on February 9, 2012
Aflac Values $750M Notes - Aflac Inc. announced the pricing of long-term fixed rate notes worth $750 million in two tranches
on February 9, 2012
O'Charley's to Join Fidelity - O'Charley's agreed to be acquired by Fidelity National Financial.
on February 9, 2012